Lipids 8: Essential Fatty Acids II Flashcards

1
Q

Where are most EFAs contained?

A

In phospholipids (n-6»>n-3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a good biomarker of EFAs?

A

phosphlipids since this is where they are mostly contained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are examples of EFA biomarkers?

A
  • Platelet & RBC phospholipids (easiest to extract)
  • Adipose tissue ~10% EFAs (4-24%) (long term reflection of diet)
  • Plasma lipids (Chylomicrons, VLDLs) (indicates diet depending what types of FAs extracted; CM short term; VLDL long term)
  • Cheek cell phospholipid DHA and AA: correlated with plasma, RBCs & diet EFAs – excellent biomarker, esp in children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the availability of EFA dependant on?

A

dietary intake!
* ↑consumption changes membrane composition to a certain extent whereas adipose tissue has no limit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the FA composition of phospholipid membranes?

A

organelle specific + influenced by diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where are EFAs on phospholipids?

A

EFAs are absorbed, transported, metabolized and incorporated in the sn-2 position on PPLs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are PPLs so heavily influenced by the diet?

A

PPLs are continuously synthesized & degraded
* head groups & fatty acyl groups can be remodelled making FA available to cell
* phospholipase A1 & A2 hydrolyze sn-1 and sn-2 respectively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What occurs with modifying the FA profile of PPLs?

A

Results in modified structure & function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What occurs with modifying the FA profile of PPLs?

A

Results in modified structure & function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the main pathways of ecosanoid synthesis?

A
  • cyclooxygenase (COX) pathway: prostaglandins & thromboxanes synthesized via the cyclic pathway
  • lipoxygenase (LOX) pathway: leukotrienes by th linear pathway)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the general synthesis for ecosanoids?

A
  • binding of a hormone or cytokine to the plasma membrane activates PLA2
  • AA released from PPL sn-2 and undergo oxidative reactions via COX or LOX (EPA and DHA too)
  • produces ecosanoid which has paracine or autocrine response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where do ecosanoids act?

A

Eicosanoids are released into extracellular fluid & act mostly locally on adjacent cells (where synthesized); autocrine (itself) &/or paracrine (cell nearby)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the main activity of ecosanoids?

A

cell-to-cell communication
Extremely potent lipid mediators acting as local messengers via signaling pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some physiological effect of ecosanoids?

A

profound physiological effects at very dilute concentrations:
* Inflammatory responses (esp joints, skin, eyes)
* Blood flow and coagulation (vascular function, regulation of blood pressure)
* Pain intensity and fever
* Reproductive function (induction of labour)
* Smooth muscle contraction and relaxation
* Gut health and integrity (inhibition of gastric acid secretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference between COX1 and COX2?

A

COX1: generates prostaglandins that are involved in the protection of gastrointestinal mucosa (normal maintenance of tissue)
COX2: generates prostaglandins that mediate inflammation and pain in sites throughout the body (acts on substrates)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

EPA/DHA vs. AA derived eicosanoids

A

EPA/ DHA derivatives are less potent/ anti-inflammatory and produce resolvins and protectins (inflammation dampening, resolution promoting lipid mediators) but are less biologically active than AA derived mediators
* AA pro-inflammatory: produces 2-series PGs, thromboxanes & 4-series LTs
* EPA anti-inflammatory: produces 3-series PGs, thromboxanes & 5-series LTs

17
Q

What competition exists between ALA and LA?

A
  • synthesis competition
  • esterification competition
  • metabolism of COX, LOX and CYP competition
18
Q

What are the types of inflammation?

A
  • acute inflammation
  • pathological inflammation
  • chronic inflammation
19
Q

EPA/DHA role in inflammation

A

dampen inflammatory response
* less inflammaotry ecosanoids
* reduces inflammatory mediators
* produce pro-resolving mediators

20
Q

How do dietary lipids modify health?

A
  • conversion to bioactive metabolites
  • modulation of transcription factor activity and gene expression
  • alteration of membrane composition and function
21
Q

health effects of n-3 FAs

A
  • improves auto-immune diseases
  • improves alzheimers
  • improves CVD
  • improves cancer cachexia
22
Q

AMDR for fats

A
  • 20-35%
  • SFA <10%E
23
Q

Guidelines for EFA intake

A
  • ~1g/d EPA+DHA people with CHD
  • 2-4g/d EPA+DHA people with high TG
24
Q

typical intake vs. DRI for PUFAs

A
  • typical intake: 8 or 10:1
  • AMDR: 5:1